Skip to main content

Phentermine/Topiramate vs GLP-1 Weight Loss Medications

Choosing an oral medicine or incretin treatment

Phentermine/Topiramate vs GLP-1 Weight Loss Medications

Phentermine/topiramate remains a strong oral option, while newer semaglutide and tirzepatide treatments may produce greater average weight loss. The right choice depends on far more than a ranking table.

Contact W8MD

Comparison at a glance

FeaturePhentermine/topiramate ERSemaglutideTirzepatide
FormDaily oral capsuleWeekly injection or approved daily tabletWeekly injection
Major-trial averageOften about 8%–11%, dose and study dependentAbout 15% with Wegovy 2.4 mg in STEP 115%–20.9% across SURMOUNT-1 doses
CostGeneric equivalents may be relatively affordableCoverage and product strongly affect costCoverage and dose strongly affect cost
Key cautionsPregnancy, glaucoma, hyperthyroidism, heart rate, mood, cognition, stones, metabolic acidosisGI disease, gallbladder, pancreatitis, dehydration, MTC/MEN 2Similar incretin cautions plus product-specific contraceptive guidance

When phentermine/topiramate may fit

It may appeal to a patient who prefers a pill, has no relevant contraindication and needs a lower-cost option. It can reduce hunger, cravings and portions. The FDA-approved extended-release combination is not identical to separately prescribed immediate-release components.

Pregnancy prevention and testing are critical because topiramate exposure can harm a fetus. Higher-dose treatment must be tapered rather than stopped abruptly.

When a GLP-1 pathway may fit

Semaglutide or tirzepatide may receive priority when greater average loss, diabetes, cardiovascular risk or Zepbound's OSA indication is especially relevant. Gastrointestinal tolerability, long-term coverage and the ability to continue treatment must be considered.

Patient comparing weight-loss medication options with medical guidance
W8MD original image, used with permission. View the source image.

How W8MD makes the decision

W8MD compares blood pressure, pulse, cardiovascular history, glaucoma, kidney stones, mood, cognition, gastrointestinal disease, diabetes, sleep apnea, pregnancy plans, prior response, injection preference, insurance and cost. No medicine wins every category.

Important: Prescription treatment requires an individualized evaluation. Eligibility, product, formulation, dose, pharmacy availability, FDA status, insurance coverage and total cost vary. Weight-loss medicines should not be used during pregnancy. Do not start, stop, combine or change a medicine without the prescribing clinician.

Frequently asked questions

Which works better?

Tirzepatide and semaglutide produced greater averages in separate major trials, but cross-trial averages do not determine the best individual treatment.

Is phentermine/topiramate cheaper?

It may be, especially with generic equivalents, but total cost and safety must be reviewed.

Can they be combined?

Combination therapy may be off-label and requires specialist evaluation and monitoring.

Related W8MD and WikiMD resources

How W8MD can help

W8MD physicians have more than 20 years of clinical experience and help patients compare medication safety, expected effectiveness, previous attempts, medical conditions, cultural food preferences, insurance benefits, convenience and complete long-term cost. Care may include prescription treatment, nutrition, a medically supervised VLCD for selected patients, sleep-apnea evaluation and weight-maintenance planning.

Brooklyn / New York City

W8MD Weight Loss, Sleep & MedSpa
2632 East 21st Street, Suite L3
Brooklyn, NY 11235

Serving Brooklyn, Manhattan, Queens, Staten Island, the Bronx, Long Island, nearby New Jersey and Connecticut communities.

Call 718-946-5500

Northeast Philadelphia

W8MD Weight Loss, Sleep & MedSpa
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115

Serving Greater Philadelphia, Bucks and Montgomery counties, South Jersey, nearby Pennsylvania communities and Delaware.

Call 215-676-2334

Visit W8MD.com Review affordable GLP-1 options

Medical notice: General education only. This article does not diagnose, prescribe or replace individualized care. Results vary. Current FDA labeling and clinical judgment control. Treatment requires evaluation; insurance approval and a prescription are not guaranteed. Call 911 for an emergency. Reviewed August 2026.
Labels:

Comments

Post a Comment

Popular posts from this blog

Best weight loss medication

2026 medication guide • W8MD Weight Loss, Sleep & MedSpa Best Weight-Loss Medications: GLP-1 Injections vs. Phentermine/Topiramate Semaglutide and tirzepatide have changed obesity treatment by producing substantially greater average weight loss than older medications. Yet oral phentermine/topiramate remains one of the most effective, popular and cost-conscious non-GLP-1 choices. W8MD physicians help patients choose based on medical conditions, safety, appetite pattern, diet preferences, previous results, insurance and the cost they can sustain. NYC: 718-946-5500 Philadelphia: 215-676-2334 20+ years of physician experience Pills and GLP-1 options Insurance and prior authorization NYC and Philadelphia offices Which medication produces the most weight loss? Among widely used FDA-approved chronic treatments, tirzepatide (Zepbound) produced the greatest average loss in its pivotal obesity trial—about 15% to 20.9% at 72 weeks across maintenance doses. Semaglutide 2.4 ...
2 comments
Read more

What you need to know about the new weight loss medication Contrave

Updated August 2026 • W8MD Weight Loss, Sleep & MedSpa Contrave for Weight Loss:  Results, Safety and Better Alternatives Contrave is an FDA-approved oral weight-management medication combining naltrexone and bupropion. It may help selected adults manage hunger and cravings, but it is less effective on average than phentermine/topiramate, Wegovy or Zepbound. W8MD physicians help patients compare expected benefit with blood pressure, seizure risk, opioid use, eating history, mood, previous medications, insurance and sustainable cost. NYC: 718-946-5500 Philadelphia: 215-676-2334 Physician supervised Pills and GLP-1 options Insurance and cost review NYC and Philadelphia offices Contrave at a glance Contrave contains 8 mg naltrexone and 90 mg bupropion in each extended-release tablet. It is used with a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity, or adults with overweight plus at least one weight-rela...
Post a Comment
Read more

Know your metabolic risk with this free metabolic meter

W8MD Weight Loss, Sleep & MedSpa Belly Fat and Metabolic Risk: What Your Waistline May Be Telling You Excess abdominal fat can be associated with insulin resistance, abnormal cholesterol, high blood pressure and type 2 diabetes—but a waistline or BMI alone cannot diagnose metabolic syndrome. A medical evaluation puts the numbers in context. Request a W8MD appointment Explore medical weight loss Quick answer: Metabolic risk is better assessed with several measurements—not appearance alone. Clinicians commonly review waist circumference, blood pressure, fasting glucose or A1C, triglycerides and HDL cholesterol, together with medical history, medications, sleep and family history. What is metabolic syndrome? Metabolic syndrome is a cluster of risk factors that raises the likelihood of type 2 diabetes, cardiovascular disease and stroke. Under commonly used criteria, an adult has metabolic syndrome when at least three of the following five findings are present. Exact cutoff...
Post a Comment
Read more